Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 812 results for "Treatment For Ovarian Cancer"

Genentech's ovarian cancer drug receives FDA acceptance for pr...

Genentech Inc., a biotechnology company, has announced the FDA acceptance and priority review for the company's supplemental biologics license application, or sBLA, of Avastin plus chemotherapy for the treatment of women with persistent, recurrent ... Individual.com, 3 days ago
[x]  

51 images for Treatment For Ovarian Cancer

Jagran Post, 1 month ago
Medical Xpress, 1 month ago
4 Traders, 2 weeks ago
Financial Express, 1 month ago
First Post.com, 1 month ago
Global News Canada, 3 weeks ago
Your Story, 1 month ago
Rediff.com, 1 month ago
Northeast Times, 4 weeks ago
Geelong Advertiser, 1 month ago
Scottrade

Precision Therapeutics, Inc. Release: Manuscript Demonstrating Chemofx Is A Predictive Marker In Ovarian Cancer Published By /i>

PITTSBURGH--(BUSINESS WIRE)--Precision Therapeutics announced today that findings from a clinical study supporting performance of the ChemoFx® drug response marker as a predictive marker have been released by British Journal of Cancer, an elite ...
 BioSpace6 days ago Manuscript Demonstrating ChemoFx is a Predictive Marker in Ovarian Cancer Published by the British Journal of Cancer  PredictWallStreet1 week ago Precision Therapeutics Supports the Annual National Ovarian Cancer Coalition (NOCC) Run/Walk to Break the Silence  BusinessWeek1 week ago Precision Therapeutics Reports ChemoFx Clinical Study  Individual.com4 days ago
[x]  

Aust cancer treatment gets US patent

Australian drug producer Prima BioMed has been granted a US patent for its ovarian cancer therapy. The company, which already holds patents for the treatment, CVac, in Australia, Japan, Canada and Europe, will hold its US patent until 2022. The ...
 NineMSN Finance1 week ago Prima picks up US patent for cancer treatment CVac  Australian Life Scientist1 week ago Prima BioMed cancer treatment gets US patent  Sydney Morning Herald1 week ago CVac: Aust cancer treatment gets US patent  Geelong Advertiser1 week ago
[x]  
Rediff.com

Now, a new treatment for ovarian cancer

Researchers claim to have developed a new treatment for ovarian cancer that can increase the rate of tumour shrinkage and prolong the time until cancers recur. Doctors at the University of Arizona Cancer Centre at St Joseph's Hospital said the new treatment can improve response rates (increase the rate of tumour shrinkage) and delay cancer progression. "Trebananib is a first-in-class peptide-Fc fusion protein (or peptibody) that targets angiogenesis (the growth of new blood vessels into ...
 Rediff.com1 month ago New treatment for ovarian cancer developed  Business Standard1 month ago
[x]  
Med India

Study Finds No Link Between Fertility Drugs and Breast, Ovarian and Uterine Cancer

There is "little evidence" that the use of conventional fertility hormones used for ovarian stimulation in the treatment of infertility increases the long-term risk of gynecological and breast cancers. This is according to the results of a substantial 30-year ...
 Med India3 weeks ago

Nanotax trail shows promise in treating abdominal cancers

A repurposed drug originally used to treat ovarian cancer saw positive results for patients with advanced peritoneal cancers during a phase I clinical trial at The University of Kansas Cancer Center. The drug, known under the brand name Nanotax, is ...
 Noodls19 hours ago
FierceMedicalDevices

FDA fast-tracks Roche's Avastin for tough-to-treat ovarian cancer

Last week, it was priority review for cervical cancer. This week, it's the fast track for difficult-to-treat ovarian cancer. That's the record for Roche's ($RHHBY) Avastin, which is now up for quick FDA approval of two new indications. The ...
 FierceMedicalDevices6 days ago FDA grants priority review for Avastin for treatment of platinum-resistant ovarian cancer  Orthopedics Today6 days ago FDA Grants Priority Review to Bevacizumab (Avastin) for Ovarian Cancer  P&T Community6 days ago FDA Grants Priority Review again to Avastin—for Recurrent, Platinum-resistant Ovarian Cancer  Oncology Times6 days ago
Reuters

EU agency recommends Roche drug for type of ovarian cancer

ZURICH (Reuters) - Roche said on Friday that European regulators had recommended approval of its drug Avastin as a treatment for women with ovarian cancer that is resistant to platinum-containing chemotherapy. Recommendations for marketing approval by the ...
 Reuters1 month ago

Vascular Biogenics IPO: Steer Clear

Summary VBLX, a clinical-stage biopharmaceutical firm, seeking to develop and commercialize treatments for cancers and immune-inflammatory diseases, plans to raise $75.6 million in its upcoming IPO. Based in Or Yehuda, Israel, we are concerned the ...
 Seeking Alpha18 hours ago

CASI receives CFDA approval to conduct Phase II breast cancer trail

CASI Pharmaceuticals, Inc., a developer of therapeutics for the treatment of cancer and other diseases, has received the China's Food and Drug Administration, or CFDA, approval for the company's application to conduct a Phase II clinical trial in ...
 Individual.com3 days ago CASI Pharmaceuticals Receives Approval From CFDA To Conduct Phase II Clinical Trial With ENMD-2076 For Triple-Negative Breast Cancer In China  Freshnews.com1 week ago CASI Pharmaceuticals Receives Approval From To Conduct Phase 2 Clinical Trial With Enmd-2076 For Triple-Negative Breast Cancer In China  BioSpace1 week ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less